No Data
Express News | Eagle Pharmaceuticals Inc - Expects to Report Its Remediation Plan and Further Information Regarding the Material Weaknesses in the Reports
Express News | Eagle Pharmaceuticals Inc - Continuing to Evaluate Its Internal Control Over Financial Reporting
Express News | Eagle Pharmaceuticals Inc Files for Non Timely 10-Q With U.S. SEC
Express News | Eagle Pharmaceuticals TO Pay Curia $26.5M, With Payments Scheduled For $10M On July 5, 2024, Another $10M By February 17, 2025, And Final $6.5M By July 7, 2025; Filed Stipulation Of Discontinuance With Prejudice For NY Court Action
Express News | Eagle Pharmaceuticals: To Pay Curia $26.5 Mln Under a Settlement Agreement
Express News | Nantahala Capital Management, LLC Reports 15.1% Passive Stake in Eagle Pharmaceuticals Inc as of June 30- SEC Filing